Tech Company Financing Transactions
Nob Hill Therapeutics Funding Round
Nob Hill Therapeutics closed a $3 million Series A funding round on 8/6/2024. Investors included Tramway Venture Partners, Tech Coast Angels and VIC Technology Venture Development.
Transaction Overview
Company Name
Announced On
8/6/2024
Transaction Type
Venture Equity
Amount
$3,000,000
Round
Series A
Investors
Tramway Venture Partners (Lead Investor) (Chris Japp)
Proceeds Purpose
The company intends to use the funds for the continued development of its high-dose respiratory technology and therapeutics, including pre-IND studies.
Company Information
Company Status
Private & Independent
Industry
Life Sciences
Mailing Address
5901 Indian School Road 209
Albuquerque, NM 87110
USA
Albuquerque, NM 87110
USA
Phone
Website
Email Address
Overview
Nob Hill Therapeutics' mission is to improve patients' lives by re-envisioning inhalation medicines and how they are delivered to the lungs. Ultimately, Nob Hill wants to change the treatment paradigm for high-dose lung delivery, and in the process is developing new technologies and therapies for lung-related diseases that can't be effectively treated today.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chairman
Paul Atkins
Chief Executive Officer
Noel Greenberger
Chief Scientific Officer
Matt Reed
Chief Technical Officer
Hugh Smyth
VP - R & D
Craig Davies-Cutting
Browse more venture capital transactions:
Prev: 8/6/2024: H3X Technologies venture capital transaction
Next: 8/6/2024: Climatize venture capital transaction
Share this article
Where The Data Comes From
We report on every notable VC transaction. VC investment data records on this site are sourced from publicly available VC deal announcements. The information is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs